Open house for Discount Agreements on the Active Substance Sodium Oxybate, ATC N07XX04
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse, EisenbergTED 497051-2026
value not stated1 lot
Fri 30 Jun23:59 in Berlin
610days
Medical supplies contracts in Germany
1,508 open tenders
Email me new onesCountryTenderValueClosesDays left
Pharmaceutical discount agreements effective as of 01.09.2026 for various active substances within an open-house procedure
AOK NordWest, HagenTED 467033-2026
value not stated8 lots
Sat 1 Jul17:00 in Berlin
611days
Open house Drug Rebate Contracts Adalimumab, ATC L04AB04
AOK Bayern - Die Gesundheitskasse, MünchenTED 486319-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Open house for pharmaceutical discount agreements on dexamethasone as an intravitreal implant, ATC S01BA01
AOK Bayern - Die Gesundheitskasse, MünchenTED 487056-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Open house for pharmaceutical discount agreements on Botulinum toxin type A, finished medicinal product name Botox(R), ATC M03AX21
AOK Bayern - Die Gesundheitskasse, MünchenTED 484691-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Open house Drug Rebate Contracts Midazolam, ATC N03AE02
AOK Bayern - Die Gesundheitskasse, MünchenTED 485613-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Open house Drug Rebate Contracts Emtricitabine, Tenofovir Disoproxil and Rilpivirine, ATC J05AR08
AOK Bayern - Die Gesundheitskasse, MünchenTED 486004-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Open house Drug Rebate Contracts Brivaracetam, ATC N03AX23
AOK Bayern - Die Gesundheitskasse, MünchenTED 486161-2026
value not stated1 lot
Mon 3 Jul12:00 in Berlin
613days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance umeclidinium + vilanterol, ATC R03AL03, for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491386-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Brolucizumab, ATC code S01LA06, for the period from 01.09.2026 to 31.08.2028
DAK-Gesundheit, HamburgTED 493642-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tacrolimus, ATC L04AD02 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 492492-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Emtricitabine + Rilpivirine + Tenofovir disoproxil fumarate, ATC J05AR08 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491642-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ranibizumab, ATC S01LA04, for the period 01.09.2026 – 31.08.2028
DAK-Gesundheit, HamburgTED 493717-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Triptorelin, ATC L02AE04 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491708-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Abatacept, ATC L04AA24 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 493555-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance natalizumab (only dosage form ILO), ATC L04AA23, for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491013-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Drug discount contracts pursuant to § 130a, paragraph 8 of the Social Code Book V (SGB V) within the framework of Open-House procedures
IKK classic, DresdenTED 599075-2026
value not stated24 lots
Wed 5 Jul23:59 in Berlin
615days
Open framework agreement on pharmaceutical discounts pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V), with possibility of accession at any time, so-called approval model 2026-09
Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 468640-2026
value not stated26 lots
Wed 5 Jul23:59 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance combination of Lopinavir and Ritonavir (ATC-Code: J05AR10).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 557912-2026
value not stated1 lot
Thu 27 Jul12:00 in Berlin
637days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Nevirapine (ATC-code: J05AG01)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 561034-2026
value not stated1 lot
Fri 28 Jul12:00 in Berlin
638days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.